ReviewExploration of targeted anti-tumor therapy2023

B-cell lymphoma 2 family members and sarcomas: a promising target in a heterogeneous disease.

Rui Caetano Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.